Market closedNon-fractional
Bausch Health/BHC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Bausch Health
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Ticker
BHC
Sector
Healthcare
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Laval, Canada
Employees
20,270
Website
www.bauschhealth.com
Bausch Health Metrics
BasicAdvanced
$2.1B
Market cap
-
P/E ratio
-$1.25
EPS
0.77
Beta
-
Dividend rate
Price and volume
Market cap
$2.1B
Beta
0.77
Financial strength
Current ratio
1.225
Quick ratio
0.631
Long term debt to equity
-12,377.011
Total debt to equity
-12,686.207
Interest coverage (TTM)
1.22%
Management effectiveness
Return on assets (TTM)
4.04%
Return on equity (TTM)
3,303.45%
Valuation
Price to revenue (TTM)
0.24
Price to book
-1.94
Price to tangible book (TTM)
-0.12
Price to free cash flow (TTM)
2.736
Growth
Revenue change (TTM)
10.01%
Earnings per share change (TTM)
26.35%
3-year revenue growth (CAGR)
3.69%
3-year earnings per share growth (CAGR)
-24.26%
What the Analysts think about Bausch Health
Analyst Ratings
Majority rating from 4 analysts.
Bausch Health Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$2.2B
-10.59%
Net income
-$64M
64.10%
Profit margin
-2.97%
84.47%
Bausch Health Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.82
$1.02
$1.15
$0.60
-
Expected
$0.76
$0.90
$1.00
$0.72
$0.88
Surprise
7.61%
13.92%
14.50%
-16.39%
-
Bausch Health News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Bausch Health stock?
Bausch Health (BHC) has a market cap of $2.1B as of July 27, 2024.
What is the P/E ratio for Bausch Health stock?
The price to earnings (P/E) ratio for Bausch Health (BHC) stock is 0 as of July 27, 2024.
Does Bausch Health stock pay dividends?
No, Bausch Health (BHC) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Bausch Health dividend payment date?
Bausch Health (BHC) stock does not pay dividends to its shareholders.
What is the beta indicator for Bausch Health?
Bausch Health (BHC) has a beta rating of 0.77. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Bausch Health stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.